Bibliography
Found 59 results
Filters: Author is Gelman, B [Clear All Filters]
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. Journal of Neurochemistry [Internet]. 2008 ;104:1504-1525. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18036154
Brain gene array reveals CNS adaptation and two different kinds of HIV-associated neurocognitive disorder. In: American Association of Neuropathologists 85 Annual Meeting. American Association of Neuropathologists 85 Annual Meeting. San Antonio, Texas; 2009. p. abstract #95.
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693
Hemochromatosis (HFE) Gene Polymorphisms and HIV-Associated Brain Pathology at Autopsy: Results of a NeuroAIDS DNA Bank Study. Jounral of Neurovirology. 2009 .
. Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia. Acta Neuropathol. 2010 ;120(1):97-108.
. Persistent “hijacking” of brain proteasomes in HIV dementia. The American Journal of Pathology [Internet]. 2010 ;176(2):893-902. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20035054#
. Synaptic Proteins Linked to HIV-1 Infection and Immunoproteasome Induction: Proteomic Analysis of Human Synaptosomes. J Neuroimmune Pharmacol [Internet]. 2010 ;5:92-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19693676
. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem [Internet]. 2011 ;286:34976-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=21816823
Search for common biological pathways in Alzheimer's disease and NeuroAIDS using gene expression microarray. In: Summit on Systems Biology. Summit on Systems Biology. Richmond, VA; 2011.
. Weighted gene co-expression network analysis of NeuroAIDS cognitive disorders. In: Summit on Systems Biology. Summit on Systems Biology. Richmond, VA; 2011.
. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443
The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment. PLoS One [Internet]. 2012 ;7(9). Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046178
Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol [Internet]. 2012 ;8:1-15. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419353/
. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV Medicine [Internet]. 2013 ;Volume 2013:5:11-22. Available from: http://www.dovepress.com/apolipoprotein-e-genotype-and-human-immunodeficiency-virus-associated--peer-reviewed-article-NBHIV
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.
Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndrome [Internet]. 2013 ;62(5):487-495. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23242157
Potential Roles of Microglial Cell Progranulin in HIV-Associated CNS Pathologies and Neurocognitive Impairment. Journal of Neuroimmune Pharmacology: the official journal of the Society on NeuroImmune Pharmacology [Internet]. 2013 ;9(2):117-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23959579
. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Medical Genomics [Internet]. 2013 ;6(4). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23406646
. Wnt signaling in the pathogenesis of human HIV-associated pain syndromes. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology [Internet]. 2013 ;8(4):956-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23737037
. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.